These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28031899)

  • 1. Development and validation of a clinical HPLC method for the quantification of hydroxychloroquine and its metabolites in whole blood.
    Qu Y; Noe G; Breaud AR; Vidal M; Clarke WA; Zahr N; Dervieux T; Costedoat-Chalumeau N; Blanchet B
    Future Sci OA; 2015 Nov; 1(3):FSO26. PubMed ID: 28031899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of a Fast Ultra-High Performance Liquid Chromatography-Fluorescent Method for the Quantification of Hydroxychloroquine and Its Metabolites in Patients With Lupus.
    Noé G; Amoura Z; Combarel D; Lori L; Tissot N; Seycha A; Funck-Brentano C; Zahr N
    Ther Drug Monit; 2019 Aug; 41(4):476-482. PubMed ID: 30807538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a novel ion-pairing HPLC-FL method for the separation and quantification of hydroxychloroquine and its metabolites in whole blood.
    Charlier B; Pingeon M; Dal Piaz F; Conti V; Valentini G; Filippelli A; Izzo V
    Biomed Chromatogr; 2018 Aug; 32(8):e4258. PubMed ID: 29669398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Sensitive and Optimized HPLC-FLD Method for the Simultaneous Quantification of Hydroxychloroquine and Its Two Metabolites in Blood of Systemic Lupus Erythematosus Patients.
    Luo X; Peng Y; Ge W
    J Chromatogr Sci; 2020 Jul; 58(7):600-605. PubMed ID: 32476003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The presumable effects of hydroxychloroquine and its metabolites in the treatment of systemic lupus erythematosus.
    Pan M; Jin R; Dai Y; Gao B; Liu Y; Peng X; Qiao J; Shuai Z
    Int Immunopharmacol; 2024 Jan; 126():111269. PubMed ID: 38006753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UHPLC-MS/MS Method for Determination of Hydroxychloroquine and Its Main Metabolites in Oral Fluid and Whole Blood for Therapeutic Drug Monitoring.
    Duarte NJC; Kupa LVK; Ferreira-Filho JCR; Fontoura N; Chalom MY; Romano P; Ebner PAR; Silva CAA; Carvalho VM; Bonfá E
    J Appl Lab Med; 2021 Jul; 6(4):868-880. PubMed ID: 33907815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a liquid chromatography tandem mass spectrometry method for the simultaneous determination of hydroxychloroquine and metabolites in human whole blood.
    Austin D; John C; Hunt BJ; Carling RS
    Clin Chem Lab Med; 2020 Sep; 58(12):2047-2061. PubMed ID: 32915766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steady-state pharmacokinetics of hydroxychloroquine in patients with cutaneous lupus erythematosus.
    Al-Rawi H; Meggitt SJ; Williams FM; Wahie S
    Lupus; 2018 Apr; 27(5):847-852. PubMed ID: 28862574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development, validation and clinical application of a LC-MS/MS method for the simultaneous quantification of hydroxychloroquine and its active metabolites in human whole blood.
    Soichot M; Mégarbane B; Houzé P; Chevillard L; Fonsart J; Baud FJ; Laprévote O; Bourgogne E
    J Pharm Biomed Anal; 2014 Nov; 100():131-137. PubMed ID: 25165008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between hydroxychloroquine levels and disease activity in a predominantly Hispanic systemic lupus erythematosus cohort.
    Geraldino-Pardilla L; Perel-Winkler A; Miceli J; Neville K; Danias G; Nguyen S; Dervieux T; Kapoor T; Giles J; Askanase A
    Lupus; 2019 Jun; 28(7):862-867. PubMed ID: 31122136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of blood and urine samples for hydroxychloroquine and three major metabolites by high-performance liquid chromatography with fluorescence detection.
    Williams SB; Patchen LC; Churchill FC
    J Chromatogr; 1988 Dec; 433():197-206. PubMed ID: 3235547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enantioselective analysis of the metabolites of hydroxychloroquine and application to an in vitro metabolic study.
    Cardoso CD; Bonato PS
    J Pharm Biomed Anal; 2005 Apr; 37(4):703-8. PubMed ID: 15797791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantioselective determination of hydroxychloroquine and its major metabolites in urine and the observation of a reversal in the (+)/(-)-hydroxychloroquine ratio.
    Fieger H; Iredale J; Wainer IW
    Chirality; 1993; 5(2):65-70. PubMed ID: 8343344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus.
    Jallouli M; Galicier L; Zahr N; Aumaître O; Francès C; Le Guern V; Lioté F; Smail A; Limal N; Perard L; Desmurs-Clavel H; Le Thi Huong D; Asli B; Kahn JE; Pourrat J; Sailler L; Ackermann F; Papo T; Sacré K; Fain O; Stirnemann J; Cacoub P; Leroux G; Cohen-Bittan J; Sellam J; Mariette X; Blanchet B; Hulot JS; Amoura Z; Piette JC; Costedoat-Chalumeau N;
    Arthritis Rheumatol; 2015 May; 67(8):2176-84. PubMed ID: 25989906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Factors Influencing Whole Blood Hydroxychloroquine Concentration in Patients with Systemic Lupus Erythematosus in China.
    Huang X; Shu Q; Luo X; Ge W; Xie H; Zhou Y
    Rheumatol Ther; 2023 Dec; 10(6):1597-1607. PubMed ID: 37755649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus.
    Costedoat-Chalumeau N; Amoura Z; Hulot JS; Hammoud HA; Aymard G; Cacoub P; Francès C; Wechsler B; Huong du LT; Ghillani P; Musset L; Lechat P; Piette JC
    Arthritis Rheum; 2006 Oct; 54(10):3284-90. PubMed ID: 17009263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study).
    Costedoat-Chalumeau N; Galicier L; Aumaître O; Francès C; Le Guern V; Lioté F; Smail A; Limal N; Perard L; Desmurs-Clavel H; Boutin du LT; Asli B; Kahn JE; Pourrat J; Sailler L; Ackermann F; Papo T; Sacré K; Fain O; Stirnemann J; Cacoub P; Jallouli M; Leroux G; Cohen-Bittan J; Tanguy ML; Hulot JS; Lechat P; Musset L; Amoura Z; Piette JC;
    Ann Rheum Dis; 2013 Nov; 72(11):1786-92. PubMed ID: 23144449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus.
    Costedoat-Chalumeau N; Amoura Z; Hulot JS; Aymard G; Leroux G; Marra D; Lechat P; Piette JC
    Ann Rheum Dis; 2007 Jun; 66(6):821-4. PubMed ID: 17324970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in systemic lupus erythematosus: description in a cohort of French patients and association with blood hydroxychloroquine levels.
    Jolly M; Galicier L; Aumaître O; Francès C; Le Guern V; Lioté F; Smail A; Limal N; Perard L; Desmurs-Clavel H; Boutin DL; Asli B; Kahn JE; Pourrat J; Sailler L; Ackermann F; Papo T; Sacré K; Fain O; Stirnemann J; Cacoub P; Jallouli M; Leroux G; Cohen-Bittan J; Hulot JS; Arora S; Amoura Z; Piette JC; Costedoat-Chalumeau N;
    Lupus; 2016 Jun; 25(7):735-40. PubMed ID: 26876692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective determination of hydroxychloroquine and its metabolites in human urine by liquid-phase microextraction and CE.
    de Oliveira AR; Cardoso CD; Bonato PS
    Electrophoresis; 2007 Apr; 28(7):1081-91. PubMed ID: 17295421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.